The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NSABP FC-11: A phase II study of neratinib (N) plus trastuzumab (T) or N plus cetuximab (C) in patients (pts) with "quadruple wild-type" metastatic colorectal cancer (mCRC) based on HER2 status.
 
Samuel A. Jacobs
Employment - Exact Sciences
 
Thomas J. George
Consulting or Advisory Role - Pfizer; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Tatjana Kolevska
Employment - The Permanente Medical Group
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Bristol Myers Squibb (I); GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
Consulting or Advisory Role - New Century Health
 
Richard Zera
No Relationships to Disclose
 
Gary L Buchschacher
Research Funding - AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Tareq Al Baghdadi
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Epizyme; HERON; Spectrum Pharmaceuticals; Sunesis Pharmaceuticals
Honoraria - Cardinal Health
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; Karyopharm Therapeutics; MorphoSys
 
Asheesh Shipstone
No Relationships to Disclose
 
Daniel Lin
Consulting or Advisory Role - Exelixis; Exelixis/Ipsen
 
Greg Yothers
Employment - Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics
 
Katherine L. Pogue-Geile
Research Funding - NSABP Foundation (Inst)
Patents, Royalties, Other Intellectual Property - A signature has been developed and an agreement has been reached with a South Korean company for commercial use of the patent to begin soon. The title of the patent is "Composition for prognosis and neoadjuvant chemoradiotherapy response prediction of rec
Travel, Accommodations, Expenses - Pfizer
 
Shannon Leigh Huggins-Puhalla
Consulting or Advisory Role - Abbvie; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Pfizer (Inst)
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Norman Wolmark
No Relationships to Disclose